| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.00074 | 1 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.00066 | 1 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.00038 | 1 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.00035 | 1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.00026 | 1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.00018 | 1 |